STRESS SIGNALING PATHWAYS LINKING ENDOTHELIAL INJURY TO GRAFT ARTERIOSCLEROSIS
STRESS SIGNALING PATHWAYS LINKING ENDOTHELIAL INJURY TO GRAFT ARTERIOSCLEROSIS
批准号:
8441476
负责人:
WANG MIN
金额:
$39.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-01 至 2016-03-31
关键词:
AcuteAffectAlloantigenAllogenicAllograftingAntioxidantsArteriesArteriosclerosisAutomobile DrivingBiological AvailabilityBlood VesselsCell Adhesion MoleculesCell physiologyChronicClinicalCouplesCytoplasmCytosolDataDelayed HypersensitivityEndothelial CellsEndotheliumExhibitsFailureFunctional disorderGene-ModifiedGenerationsHeart TransplantationHeart failureHumanHydrogen PeroxideHyperplasiaHypoxiaImmune systemIn VitroIncidenceInflammatory ResponseInjuryIntercellular adhesion molecule 1Interferon Type IIInterferonsInterleukin-1Interleukin-2Interleukin-6Intracellular Signaling ProteinsIschemiaKnock-outKnockout MiceLinkMediatingMediator of activation proteinMitochondriaModelingMusNADPH OxidaseOxidasesOxidative StressPathogenesisPatientsProductionProteinsReactive Oxygen SpeciesReperfusion TherapyRespirationRoleSignal PathwaySignal TransductionStenosisStressSystemT cell responseT-Cell ActivationT-LymphocyteTestingTherapeuticThioredoxin-2Transgenic MiceVascular Cell Adhesion Molecule-1Vascular Diseasesallograft rejectionbasebiological adaptation to stressheart allograftimmunogenicityin vivoinjuredisoimmunitypreventprotective effectresponsesuccessvascular smooth muscle cell proliferation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall hypothesis of this application is that graft arteriosclerosis (GA), the major cause of late cardiac allograft failure, results from a chronic hot T cell response to allogeneic graft endothelial cells (ECs) that takes the form of delayed-type hypersensitivity DTH within the vessel wall, locally generating IFN-g which is responsible for driving vascular smooth muscle cell (VSMC) proliferation and intimal hyperplasia. The clinical correlations and evidence from other experimental systems have suggested that non-immune factors, especially peri-operative stress-induced alterations in the graft, are important contributors to GA pathogenesis. It is proposed and demonstrated experimentally that signals in the graft, primarily from ECs, generated as a result of peri-operative stress can produce mediators that influence T cell activation and differentiation. However, how the peri-operative stresses such as hypoxia couple intracellular signaling pathway to alter ECs alloimmunity and GA is not understood, and is the subject of this project. We have identified two major intracellular signaling proteins- cytosolic ASK1-interacting protein-1 (AIP1) and mitochondrial thioredoxin-2 (Trx2) in ECs that protect ECs from oxidative stress-induced injuries. Specifically, AIP1 in the cytoplasm via its inhibitory effect on the NADPH oxidase (Nox) while Trx2 in mitochondria via its anti-oxidant activity, prevent ischemia-reperfusion-elicited ROS and oxidative stress-induced inflammatory responses. In this proposal, we hypothesize that the responses to non-immune peri-operative injuries of graft endothelial cells (EC) are modulated by Trx2 in the mitochondria and AIP1 in the cytosol, altering the EC in a manner that affects T cell- mediated alloimmunity and GA. We propose to explore this hypothesis in the following specific aims: 1) Characterize AIP1-regulated cytosolic signaling pathways that mediate peri-operative stress-induced responses that alter EC immunogenicity and GA progression. 2) Characterize Trx2-regulated mitochondrial signaling pathways that mediate peri-operative stress-induced responses that alter EC immunogenicity and GA progression. If successful, this study will provide therapeutic strategies by modulating these two molecules in ECs to reduce GA incidence or delay GA progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of signaling molecule AIP1 in pathological angiogenesis
-
批准号:8578663
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2013
-
负责人:WANG MIN
-
依托单位:
The role of signaling molecule AIP1 in pathological angiogenesis
-
批准号:8706216
-
项目类别:
-
资助金额:$40.86万
-
财政年份:2013
-
负责人:WANG MIN
-
依托单位:
The role of signaling molecule AIP1 in pathological angiogenesis
-
批准号:8868164
-
项目类别:
-
资助金额:$41.07万
-
财政年份:2013
-
负责人:WANG MIN
-
依托单位:
STRESS SIGNALING PATHWAYS LINKING ENDOTHELIAL INJURY TO GRAFT ARTERIOSCLEROSIS
-
批准号:8292774
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2012
-
负责人:WANG MIN
-
依托单位:
Thioredoxin and Endothelial Cell Function
-
批准号:8309173
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2008
-
负责人:WANG MIN
-
依托单位:
Thioredoxin and Endothelial Cell Function
-
批准号:7676147
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2008
-
负责人:WANG MIN
-
依托单位:
Thioredoxin and Endothelial Cell Function
-
批准号:7530934
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2008
-
负责人:WANG MIN
-
依托单位:
Thioredoxin and Endothelial Cell Function
-
批准号:7896738
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2008
-
负责人:WANG MIN
-
依托单位:
SOCS-1 and endothelial dysfunction in graft arteriosclerosis
-
批准号:7491182
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2007
-
负责人:WANG MIN
-
依托单位:
TNF receptor-2 signaling in arteriogenesis/angiogenesis
-
批准号:7586694
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2007
-
负责人:WANG MIN
-
依托单位:
TNF receptor-2 signaling in arteriogenesis/angiogenesis
-
批准号:7390637
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2007
-
负责人:WANG MIN
-
依托单位:
TNF receptor-2 signaling in arteriogenesis/angiogenesis
-
批准号:7797550
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2007
-
负责人:WANG MIN
-
依托单位:
TNF receptor-2 signaling in arteriogenesis/angiogenesis
-
批准号:7267576
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2007
-
负责人:WANG MIN
-
依托单位:
SOCS-1 and endothelial dysfunction in graft arteriosclerosis
-
批准号:7297619
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2006
-
负责人:WANG MIN
-
依托单位:
INHIBITING JNK, A NEW ANTI-INFLAMMATORY STRATEGY
-
批准号:6527672
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2000
-
负责人:WANG MIN
-
依托单位:
INHIBITING JNK, A NEW ANTI-INFLAMMATORY STRATEGY
-
批准号:6630378
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2000
-
负责人:WANG MIN
-
依托单位:
Inhibiting JNK A New Anti-Inflammatory Strategy
-
批准号:6921367
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2000
-
负责人:WANG MIN
-
依托单位:
Inhibiting JNK A New Anti-Inflammatory Strategy
-
批准号:7095115
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2000
-
负责人:WANG MIN
-
依托单位:
INHIBITING JNK, A NEW ANTI-INFLAMMATORY STRATEGY
-
批准号:6390926
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2000
-
负责人:WANG MIN
-
依托单位:
Inhibiting JNK A New Anti-Inflammatory Strategy
-
批准号:6775346
-
项目类别:
-
资助金额:$40.24万
-
财政年份:2000
-
负责人:WANG MIN
-
依托单位:
海外基金